BioSpace News Archive

InspireMD, Inc., the developer of the CGuard™ Embolic Prevention System for the prevention of stroke caused by carotid artery disease, announced the appointment of Patrick Jamnik as vice president, business development and strategic initiatives.

Gamida Cell Ltd., an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, announced that the Phase 3 study of omidubicel, an investigational advanced cell therapy in development as a potential life-saving treatment option for patients in need of bone marrow transplant, met all three of its secondary endpoints.

Patients on REYVOW had 3.8-7.2 Times Greater Odds of Achieving Pain Freedom at 2 Hours Versus Placebo in At Least 2 out of 3 Attacks, Resulting in Significant Therapeutic Gains of 10-20%

Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for SB11, a proposed biosimilar referencing Lucentis®.

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, announced that the company plans to present at the following conferences.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that it will present at the following virtual conferences in October:

Castle Biosciences, Inc., a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, announced that its data will be featured in oral presentations during the 2020 American Society for Dermatologic Surgery Virtual Annual Meeting, October 9-11, 2020.

Drug delivery is a prominent process in healthcare, especially in the current scenario for a variety of reasons.

Transparency Market Research has published a new report titled, ‘Small bone and joint orthopedic devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global needle biopsy market was valued at ~US$ 630 Mn in 2019.